December 18, 2017 / 7:03 PM / 10 months ago

BUZZ-Valeant Pharma: Begins eye drug shipments to U.S. wholesalers

** U.S.-listed shares of Canadian drugmaker up 9 pct at $21.51 as company begins distributing its glaucoma drug to U.S. wholesale pharmaceutical distributors

** Co says its Vyzulta, which was approved last month, will be available to patients across the United States through their local pharmacies within the next few days

** Vyzulta, which the FDA previously rejected twice, could be a blockbuster drug for VRX, Cantor Fitzgerald’s Louise Chen noted, following the approval

** Up to Friday’s close, VRX stock had risen nearly 36 pct YTD (Reporting by Tamara Mathias in Bengaluru)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below